Skip to content
Unrated Drug recall · FDA · Published July 22, 2019

Wise Pharmacy recalls injectable medication due to processing control issues

Wise Pharmacy recalls specific compounded injectable medication batches due to lack of processing controls. Affected lots expire by July 2019. Consumers should contact the pharmacy for details.

🇺🇸 FDA recall #D-1575-2019DrugWise Pharmacy ›
Take action

Contact the company

Recalling firmWise Pharmacy6179 S Balsam Way Ste 150 · Littleton, CO 80123-3095
✎ GovInfoNow plain-language explainer

What happened, in plain English

Wise Pharmacy has recalled certain compounded injectable medications because of processing control issues. This could affect patients using these medications under a prescription. Read more at govinfonow.com/recall/38250-wise-pharmacy-recalls-injectable-medication-due-to-processing-control-issues.

Source Summary by GovInfoNow · govinfonow.com/recall/38250-wise-pharmacy-recalls-injectable-medication-due-to-processing-control-issues · Updated October 5, 2026 · FDA enforcement record: FDA #D-1575-2019

Cite this page

“Wise Pharmacy recalls injectable medication due to processing control issues.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/38250-wise-pharmacy-recalls-injectable-medication-due-to-processing-control-issues. Based on FDA recall #D-1575-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1575-2019%22&limit=1).

Why it’s dangerous

The recall is due to a lack of processing controls during compounding, which may lead to medication inconsistencies. However, the exact risk to patients is not specified in the recall notice.

Who’s affected

Patients prescribed this compounded medication by a healthcare provider in the United States. Those with specific lot numbers are most at risk.

How to tell if you have this one

Check the lot number on the vial: 5620N (expires 7/16/2019), 6221N (expires 8/31/2019), or 6952N (expires 10/16/2019). This medication is only available by prescription.

  • Brand
    Wise Pharmacy
  • Category
    Drug
FDA recall event · 11 products

All 11 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    CO, TX, WY
Recall numberProduct, codes & lotsQuantity
D-1567-2019Acetylcysteine 2% Otic Drop, 15 mL bottle, Rx only, Refrigerate, Compounded by Wise Pharmacy, Littleton, CO 80123.; Lot #: 7131N, Exp 7/11/191 bottle
D-1568-2019Alprostadil 100 mcg/mL Injectable, 2.5 mL vial, Rx only, Compounded by Wise Pharmacy, Littleton, CO 80123.; Lot #: 6981N, Exp 10/17/20194 vials
D-1569-2019Dexamethasone Sodium Phosphate PF 24 mg/mL Injection, Refrigerate, Single Use Vial, 1 mL vial, Rx only, Compounded by Wise Pharmacy, Littleton, CO 80123.; Lots #: 5506N, Exp 9/21/2019; 7180N, Exp 12/29/201927 vials
D-1570-2019Gentamicin (GU) Irrigation 240 mg/500 mL Solution, 250 mL Container, Shake well and Refrigerate, Rx only, Compounded by Wise Pharmacy, Littleton, CO 80123.; Lot #: 7179N, Exp 7/16/20191 container
D-1571-2019Tobramycin Irrigation 80 mg/1000 mL Solution, 1000 mL Container, Refrigerate, Nasal,, Rx only, Compounded by Wise Pharmacy, Littleton, CO 80123.; Lot #: 7270N, Exp 7/22/20191 container
D-1572-2019Papaverine/Phentolamine 30 mg/1 mg/mL Injectable, 2.5 mL Vial, Rx only, Compounded by Wise Pharmacy, Littleton, CO 80123.; Lot #: 5978N, Exp 8/20/2019; 7266N, Exp 11/5/20198 vials
D-1573-2019Papaverine/Phentolamine/Alprostadil 30 mg/0.2 mg/10 mcg/mL Injectable, 2.5 mL Vial, Rx only, Compounded by Wise Pharmacy, Littleton, CO 80123.; Lot #: 6054N; 4796N, Exp 7/16/2019; 7049N, Exp 11/24/201984 vials
D-1574-2019Papaverine/Phentolamine/Alprostadil - 30 mg/1 mg/10 mcg/mL Injectable, 2.5 mL Vial, Rx only, Compounded by Wise Pharmacy, Littleton, CO 80123.; Lot #: 5333N, Exp 7/12/2019; 7000N, Exp 10/18/201944 vials
D-1575-2019Papaverine/Phentolamine/Alprostadil 30 mg/2 mg/30 mcg/mL Injectable, 2.5 mL Vial, Rx only, Compounded by Wise Pharmacy, Littleton, CO 80123.; Lot #: 5620N, Exp 7/16/2019; 6221N, Exp 8/31/2019; 6952N, Exp 10/16/201997 vials
D-1576-2019Papaverine/Phentolamine/Alprostadil 30 mg/2 mg/50 mcg/mL Injectable, 2.5 mL Vial, Rx only, Compounded by Wise Pharmacy, Littleton, CO 80123.; Lot #: 6176N, Exp 8/30/2019; 7162N, Exp 10/20/201932 vials
D-1577-2019Papaverine/Phentolamine/Alprostadil/Atropine 30 mg/2 mg/50 mcg/0.15 mg/mL Injectable, 2.5 mL Vial, Rx only, Compounded by Wise Pharmacy, Littleton, CO 80123.; Lot #: 6153N, Exp8/29/201914 vials
Based on the official FDA remedy

What to do — step by step

  1. Contact Wise Pharmacy

    Reach out to Wise Pharmacy in Littleton, CO for specific instructions on handling the recalled medication.

Where it went and when

Where it was distributed

Distributed in 3 states.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: yesWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: yesCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: yesTXFlorida: not listedFL

FDA distribution: “CO, TX, WY” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Colorado, Texas, Wyoming.

Recall timeline

FDA terminated this recall 6 months after the firm started it.

1. Firm started the recall: Jul 22, 201912. FDA classified it Class II: Jul 31, 201923. Published in FDA’s Enforcement Report: Aug 7, 201934. FDA terminated the recall: Feb 3, 2020420192020
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1575-2019 (July 22, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1575-2019 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA